Loading…
CIK 0001512848 • 6 13F filings • May 14, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("nea-management-company-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| Arcellx, Inc. | COMMON STOCK | $198.6M | 10.1% | 3,045,262 SH | New |
| Aurinia Pharmaceuticals, Inc. | COM | $63.3M | 3.2% | 3,969,834 SH | New |
| Black Diamond Therapeutics, Inc. | COM | $10.8M | 0.6% | 4,448,757 SH | New |
| Celcuity Inc. | COM | $352.6M | 18.0% | 3,535,561 SH | New |
| Champions Oncology, Inc. | COM NEW | $11.8M | 0.6% | 1,713,720 SH | New |
| Coursera, Inc. | COM | $94.7M | 4.8% | 12,867,769 SH | New |
| CRISPR Therapeutics AG | NAMEN AKT | $55.5M | 2.8%Prev: 3.8% | 1,058,570 SH | Decreased |
| CVRx, Inc. | COM | $14.4M | 0.7% | 2,026,083 SH | New |
| Gossamer Bio, Inc. | COM | $56.1M | 2.9% | 18,093,034 SH | New |
| ImageneBio, Inc. | COM | $345K | 0.0% | 50,005 SH | New |
| Inventiva SA | ADS | $6.8M | 0.3%Prev: 0.5% | 1,462,586 SH | Decreased |
| Korro Bio, Inc. | COM | $8.7M | 0.4% | 1,090,793 SH | New |
| LeonaBio, Inc. | COM | $3.5M | 0.2% | 464,398 SH | New |
| Marker Therapeutics, Inc. | COM NEW | $2.4M | 0.1% | 1,625,678 SH | New |
| MBX Biosciences, Inc. | COM | $114.0M | 5.8% | 3,614,486 SH | New |
| Monte Rosa Therapeutics, Inc. | COM | $120.6M | 6.2% | 7,692,298 SH | New |
| Nkarta, Inc. | COM | $6.6M | 0.3% | 3,568,781 SH | New |
| OnKure Therapeutics, Inc. | COM CL A | $1.4M | 0.1% | 478,548 SH | New |
| ORIC Pharmaceuticals, Inc. | COM | $33.7M | 1.7% | 4,118,621 SH | New |
| Phathom Pharmaceauticals, Inc. | COM | $32.5M | 1.7% | 1,960,169 SH | New |
| Rhythm Pharmaceuticals, Inc. | COM | $311.5M | 15.9% | 2,909,956 SH | New |
| Savara, Inc. | COM | $147.6M | 7.5% | 24,471,264 SH | New |
| Senti Biosciences, Inc. | COM NEW | $3.9M | 0.2% | 3,775,615 SH | New |
| Synlogic, Inc. | COM NEW | $3.3M | 0.2% | 2,922,772 SH | New |
| Trevi Therapeutics, Inc. | COM | $165.5M | 8.4% | 13,222,228 SH | New |
| X4 Pharmaceuticals, Inc. | COM | $12.9M | 0.7% | 3,233,743 SH | New |
| Zenas BioPharma, Inc. | COM | $127.9M | 6.5% | 3,523,219 SH | New |
| 13F-HR |
| 0001072613-26-000684 |
| $1.59B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000897069-25-001334 | $1.33B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001072613-26-000458 | $1.76B | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0000897069-25-000979 | $1.30B | View |